Skip to main content

Free Content HIV serological screening in a population of pregnant women in the Republic of Congo: suitability of different assays

Download Article:

You have access to the full text article on a website external to Ingenta Connect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

Summary

Different strategies can be applied for the screening of HIV infection, depending on the local seroprevalence. Within a WHO type III strategy, we compared the results of two different second-line methods for HIV screening of a population of pregnant women in the Republic of Congo. Sera from 3614 consecutive pregnant women were tested for HIV with Genescreen Plus Ag/Ab EIA assay; positive specimens were retested with two different second-line methods. (Determine HIV-1/2 rapid test and Vironostika HIV Ag/Ab specific EIA assay). Discordant samples were tested with HIV-1/2 Western Blot and, if necessary, HIV RNA molecular assay. Of the 3614 sera, 221 were positive with Genscreen. Among them, 21 and 10 tested negative with Vironostika and Determine, respectively. A 100% correspondence with 3rd line confirmation test results was found in Genscreen positive/Vironostika negative samples, whereas a 5.5% overestimation of HIV seroprevalence was observed when Determine, instead of Vironostika, was used as second-line test. The choice of appropriate assays in adequate sequence, within the correct WHO strategy, is pivotal to minimize the risk of overtreatment of HIV infection.

Keywords: HIV screening; Republic of Congo; WHO strategies; assays; pregnant women; prevalence

Document Type: Research Article

DOI: https://doi.org/10.1111/j.1365-3156.2008.02090.x

Affiliations: 1:  Hygiene Unit, S. Martino Hospital, Genoa, Italy 2:  Division of Infectious Diseases, University of Genoa and San Martino University Hospital, Genoa, Italy 3:  Department of Health Sciences, University of Genoa, Genoa, Italy 4:  Kento-Muana Laboratory, Hôpital Régional des Armées, Pointe Noire, République du Congo 5:  ENI E & P, San Donato Milanese, Milan, Italy

Publication date: 2008-07-01

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more